Relationship between low‐dose amphetamine‐induced arousal and extracellular norepinephrine and dopamine levels within prefrontal cortex
The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Despite the well‐known and potent arousal‐enhancing effects of amphetamine (AMPH)‐like stimulants, the neurobiological substrates of AMPH‐induced arousal have rarely been examined explicitly. Available evidence suggests the possible participation of noradrenergic and/or dopaminergic systems in the arousal‐enhancing actions of AMPH‐like stimulants. The current studies examined the extent to which low‐dose AMPH‐induced increases in waking are related to AMPH‐induced increases in extracellular norepinephrine (NE) and dopamine (DA) levels within the prefrontal cortex (PFC), as measured by in vivo microdialysis. Vehicle injections elicited brief epochs of waking. Vehicle‐induced waking was closely associated with a brief and moderate (50% above baseline) increase in NE levels. DA levels were less sensitive to the arousing actions of vehicle injections, with maximal increases of approximately 25% above baseline observed. 0.15 mg/kg and 0.25 mg/kg AMPH increased time spent awake, which resulted primarily from increases in quiet waking. Although the magnitude of the waking response did not differ substantially between the two doses across time, a trend for a more rapid recovery to baseline waking levels was observed at the higher dose, possibly suggesting the development of a relatively rapid‐onset tolerance to the wake‐promoting actions of AMPH at this dose. At the 0.15 mg/kg dose, AMPH elicited maximum increases of approximately 175% and 125% above baseline levels for NE and DA, respectively. The time course of AMPH‐induced increases in waking closely paralleled the time course of AMPH‐induced increases in both NE and DA efflux. These observations are consistent with the hypothesis that both increased DA and NE efflux contribute to the low‐dose behavioral effects of AMPH‐like stimulants, including the arousal‐enhancing actions of these drugs. Additionally, these observations also suggest a possibly greater sensitivity of NE efflux, relative to DA, to moderately arousing conditions including low‐dose AMPH‐like stimulant administration. Synapse 46:140–149, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A psychomotor stimulant theory of addiction.
Wise, R. A., & Bozarth, M. A. (1987) · Psychological Review · doi:10.1037/0033-295x.94.4.469 · Cited by 2,747
Cellular and molecular mechanisms of drug dependence
Koob, G. F., & Bloom, F. E. (1988) · Science · doi:10.1126/science.2903550 · Cited by 2,070
Aston-Jones, G., & Bloom, F. (1981) · The Journal of Neuroscience · doi:10.1523/jneurosci.01-08-00876.1981 · Cited by 1,960
Nucleus locus ceruleus: new evidence of anatomical and physiological specificity
Foote, S. L., Bloom, F. E., & Aston-Jones, G. (1983) · Physiological Reviews · doi:10.1152/physrev.1983.63.3.844 · Cited by 1,901
Foote, S. L., Aston-Jones, G., & Bloom, F. E. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.5.3033 · Cited by 857 · cited 2×
“…exerts a robust activating influence on both the state of forebrain circuits as well as on behavioral state (e.g., arousal; Hobson et al., 1975; Foote et al., 1980; AstonJones and Bloom, 1981; Berridge and Foote, 1991, 1996; Berridge et al., 1996; Mallick and Alam, 1992; Sood et al., 1997;…”
BackgroundKuczenski, R., & Segal, D. S. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052032.x · Cited by 623
Kuczenski, R., Segal, D., Cho, A., & Melega, W. (1995) · The Journal of Neuroscience · doi:10.1523/jneurosci.15-02-01308.1995 · Cited by 376 · cited 3×
“However, in contrast to that of DA and NE, AMPHinduced enhancement of extracellular serotonin levels occurs only at doses of AMPH that greatly exceed those used in the current studies (Kuczenski et al., 1995).”
BackgroundStress and the Mesocorticolimbic Dopamine Systemsa
ROTH, R. H., TAM, S., IDA, Y., YANG, J., & DEUTCH, A. Y. (1988) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1988.tb42102.x · Cited by 342 · cited 4×
“For example, dopaminergic neurons display state-dependent alterations in rates of neurotransmission (Thierry et al., 1976; Dunn, 1988; Roth et al., 1988; D’Angio and Scatton, 1989; Ahn and Phillips, 1999; Bassareo and Di Chiara, 1999; Smith et al., 1992; Trulson, 1985).”
BackgroundInfluentialKuczenski, R., & Segal, D. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-16-07264.2002 · Cited by 316
Cited by
Berridge, C. W., & Waterhouse, B. D. (2003) · Brain Research Reviews · doi:10.1016/s0165-0173(03)00143-7 · Cited by 2,529
Self-citationBerridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B., Hamilton, C., & Spencer, R. C. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.04.022 · Cited by 617
Self-citationNoradrenergic modulation of arousal
Berridge, C. W. (2008) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.10.013 · Cited by 368
Self-citationArnsten, A. F., & Dudley, A. G. (2005) · Behavioral and Brain Functions · doi:10.1186/1744-9081-1-2 · Cited by 363
Noradrenergic modulation of wakefulness/arousal
Berridge, C. W., Schmeichel, B. E., & España, R. A. (2012) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2011.12.003 · Cited by 346
Self-citationWhat Keeps Us Awake: the Neuropharmacology of Stimulants and Wakefulness Promoting Medications
Boutrel, B., & Koob, G. F. (2004) · Sleep · doi:10.1093/sleep/27.6.1181 · Cited by 307
Stimulants and the developing brain
Andersen, S. L. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.03.009 · Cited by 168
The Cognition-Enhancing Effects of Psychostimulants Involve Direct Action in the Prefrontal Cortex
Spencer, R. C., Devilbiss, D. M., & Berridge, C. W. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.09.013 · Cited by 164
“that are associated with significant potential for abuse (1-6).”
Self-citationBerridge, C. W., & Devilbiss, D. M. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.06.023 · Cited by 160
Self-citationPsychostimulants and motivated behavior: Arousal and cognition
Berridge, C. W., & Arnsten, A. F. T. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.11.005 · Cited by 104
Self-citationConnor, D. F., Findling, R. L., Kollins, S. H., Sallee, F., López, F. A., Lyne, A., & Tremblay, G. (2010) · CNS Drugs · doi:10.2165/11537790-000000000-00000 · Cited by 101
Reverse translational strategies for developing animal models of bipolar disorder
Malkesman, O., Austin, D. R., Chen, G., & Manji, H. K. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001628 · Cited by 70
Pascoli, V., Valjent, E., Corbillé, A.-G., Corvol, J.-C., Tassin, J.-P., Girault, J.-A., & Hervé, D. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.011809 · Cited by 59
“In the prefrontal cortex, D-amph and MPH share the ability to increase extracellular DA and NE (Berridge and Stalnaker, 2002).”
BackgroundLapish, C. C., Balaguer-Ballester, E., Seamans, J. K., Phillips, A. G., & Durstewitz, D. (2015) · Journal of Neuroscience · doi:10.1523/jneurosci.2421-14.2015 · Cited by 45
Metadata
- Authors
- Berridge, C. W., & Stalnaker, T. A.
- Venue
- Synapse
- Publisher
- Wiley
- Published
- 2002-09-03
- Volume
- 46
- Issue
- 3
- Pages
- 140-149
- ISSN
- 0887-4476 (ISSN-L)
- 1098-2396
- OpenAlex
- W1999780060
- Cited by
- 86
- References
- 9
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.